

Fundamental dimension Equity attribute | AQBLeader $1.11▲+8.82% Cap $5.71MP/E -0.2x QuantScore51/100 | AGRIPeer $0.7656▲+0.74% Cap $1.92MP/E -0.1x QuantScore46/100 | AMZEPeer $0.112▼-11.60% Cap $2.33MP/E -0.0x QuantScore27/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
83/100 |
18/100 |
45/100 |
Valuation Multiples, PEG & DCF upside | 0/100 | 33/100 | 0/100 |
Health Piotroski, Altman Z, leverage & liquidity | 43/100 | 47/100 | 17/100 |
Growth Revenue / earnings growth & margins | 50/100 | 31/100 | 46/100 |
Sentiment Analyst ratings, targets & revisions | 81/100 | 100/100 | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -0.2x | -0.1x | -0.0x |
Forward P/E (next FY) | -0.2x | — | -0.1x |
EV / EBITDA (TTM) | -2.0x | 0.1x | -0.1x |
Price / Sales | — | 0.4x | 1.1x |
Price / Free Cash Flow | -0.8x | -1.9x | -0.7x |
PEG ratio | -0.00 | -0.00 | -0.00 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 3 / 9 | 4 / 9 | 3 / 9 |
Altman Z-Score | -46.07 (Distress) | -4.36 (Distress) | -10.60 (Distress) |
Total debt / equity | 0.00 | 0.00 | 0.66 |
Quick ratio | 4.3x | — | 0.2x |
Interest coverage | -1.0x | 67.0x | -24.2x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | — | -100.0% | +557.8% |
Net income growth YoY | +87.6% | -104.0% | -2090.0% |
Gross margin (TTM) | 0.0% | 67.2% | 33.8% |
Operating margin (FY) | — | — | -1021.7% |
FCF margin (FY) | — | — | -898.7% |
5. Trailing price performancePrice change over period |
1M return | +16.8% | 0.0% | -15.8% |
3M return | +22.0% | -58.2% | -84.8% |
6M return | +13.9% | -78.9% | -91.3% |
Year to date | +19.4% | -52.4% | -96.3% |
1Y return | -25.0% | -93.9% | -98.6% |
3Y return | -59.3% | -100.0% | -99.9% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-0.8561 -177.1% premium | $-2.61 -440.6% premium | $-3.03 -2806.8% premium |
Wall Street consensus target | $3.00 +170.3% · range $2.00–$4.00 | — — | — — |
Consensus stance | 67% Buy33% Hold0% Sell | 100% Buy0% Hold0% Sell | — |